KYPROLIS
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
76075-101 -
Package NDC
76075-101-01 -
Package NDC
76075-101-21 -
Application number
NDA202714 -
SPL ID
600cd22c-3a74-442e-a65d-c06d47bb892a -
SPL set ID
ea66eb30-e665-4693-99a1-a9d3b4bbe2d6 -
UNII
72X6E3J5AR -
RxCUI
1806934 -
RxCUI
1806937 -
RxCUI
1806940 -
RxCUI
1806942 -
RxCUI
2046642 -
RxCUI
2046644
What the source publishes
- Labeler
- Onyx Pharmaceuticals, Inc.
- Active ingredients
- carfilzomib
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- NDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "KYPROLIS",
"splId": "600cd22c-3a74-442e-a65d-c06d47bb892a",
"labels": [
{
"setId": "ea66eb30-e665-4693-99a1-a9d3b4bbe2d6",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ea66eb30-e665-4693-99a1-a9d3b4bbe2d6",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=ea66eb30-e665-4693-99a1-a9d3b4bbe2d6"
}
],
"routes": [
"INTRAVENOUS"
],
"labeler": "Onyx Pharmaceuticals, Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL, SINGLE-USE in 1 CARTON (76075-101-01) / 30 mL in 1 VIAL, SINGLE-USE",
"package_ndc": "76075-101-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20120720"
},
{
"sample": false,
"description": "1 VIAL, SINGLE-USE in 1 CARTON (76075-101-21) / 30 mL in 1 VIAL, SINGLE-USE",
"package_ndc": "76075-101-21",
"identifierStatus": "well-formed",
"marketing_start_date": "20251001"
}
],
"productId": "76075-101_600cd22c-3a74-442e-a65d-c06d47bb892a",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "76075-101",
"deaSchedule": null,
"genericName": "carfilzomib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "CARFILZOMIB",
"strength": "60 mg/30mL"
}
],
"applicationNumber": "NDA202714",
"marketingCategory": "NDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20120720",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175604",
"N0000175075"
],
"unii": [
"72X6E3J5AR"
],
"rxcui": [
"1806934",
"1806937",
"1806940",
"1806942",
"2046642",
"2046644"
],
"spl_set_id": [
"ea66eb30-e665-4693-99a1-a9d3b4bbe2d6"
],
"pharm_class_epc": [
"Proteasome Inhibitor [EPC]"
],
"pharm_class_moa": [
"Proteasome Inhibitors [MoA]"
],
"manufacturer_name": [
"Onyx Pharmaceuticals, Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:76075-101_600cd22c-3a74-442e-a65d-c06d47bb892a"